Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02493569
Recruitment Status : Unknown
Verified August 2016 by First Affiliated Hospital Xi'an Jiaotong University.
Recruitment status was:  Not yet recruiting
First Posted : July 9, 2015
Last Update Posted : August 10, 2016
Sponsor:
Information provided by (Responsible Party):
First Affiliated Hospital Xi'an Jiaotong University

Brief Summary:
The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Condition or disease Intervention/treatment
Breast Cancer Procedure: The radical mastectomy of breast cancer

Detailed Description:
The study is a multicentric, retrospective clinical study based on the hospital. The target number of cases are X patients who are eligible for breast cancer after radical mastectomy. To collect the clinicopathological data and treatment data of the breast cancer patients and do the follow-up visit of all the patients who are included in the study.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3000 participants
Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)
Study Start Date : October 2016
Estimated Primary Completion Date : October 2017

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Epidemiology breast cancer patients
Observe the features of clinical diagnosis and treatment for female breast cancer patients
Procedure: The radical mastectomy of breast cancer
The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.




Primary Outcome Measures :
  1. Overall five-year survival for the female breast cancer patients [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The female breast cancer patients in Shaanxi Province of China, those study population shoud be the hospitalized patients who are confirmed of the primary breast cancer histologically, moreover, the date of the inpatients are within the month we chosen and those inpatients should have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.
Criteria

Inclusion Criteria:

  • Female patients;
  • The hospitalized patients who are confirmed of the primary breast cancer histologically;
  • The date of the inpatients are within the month we chosen;
  • Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

Exclusion Criteria:

  • Male breast cancer patients;
  • Patients with breast cancer who are not under the chosen time;
  • Non hospitalized patients.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02493569


Contacts
Layout table for location contacts
Contact: Yu Ren, MD,PhD 13700222161 renyyyyy@126.com

Sponsors and Collaborators
First Affiliated Hospital Xi'an Jiaotong University
Investigators
Layout table for investigator information
Principal Investigator: Yu Ren, MD,PhD First Affiliated Hospital Xi'an Jiaotong University

Layout table for additonal information
Responsible Party: First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier: NCT02493569    
Other Study ID Numbers: KYLLSL-2015-153-01
First Posted: July 9, 2015    Key Record Dates
Last Update Posted: August 10, 2016
Last Verified: August 2016
Keywords provided by First Affiliated Hospital Xi'an Jiaotong University:
Breast cancer, hospital, epidemiology, diagnosis, treatment
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases